Drugs / Gaviscon Advance
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03516188 | Jul 2016 → Jun 2017 | gastroesophageal reflux disease, obesity disorder | Universiti Sains Malaysia | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gaviscon Advance | “alginate-antacid preparation (Gaviscon-Advance®, Reckitt-Benckiser, United Kingdom)” NCT03516188 ↗1“Gaviscon Advance (GA)®, Reckitt Benckiser, UK” NCT03516188 ↗ |